Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody Deficiency”

363 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 363 results

Not applicableUnknownNCT04563650
What this trial is testing

COVID-19 Serology and Immunosenescence

Who this might be right for
Covid19Geriatric MedicineSeroconversion+1 more
Centre Hospitalier Universitaire, Amiens 98
Large-scale testing (Phase 3)Study completedNCT03988426
What this trial is testing

Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases

Who this might be right for
Primary Immune Deficiency Disorder
Octapharma 25
Not applicableLooking for participantsNCT05664035
What this trial is testing

Frequency of SPAD in Adult Patients

Who this might be right for
Specific Antibody DeficiencyPredominantly Antibody Deficiencies
University Hospital, Lille 99
Early research (Phase 1)Study completedNCT00000886
What this trial is testing

A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableNot Yet RecruitingNCT07516002
What this trial is testing

Immunoglobulin Efficacy and Immune Profiling in Antibody Immunodeficiency

Who this might be right for
Primary Immunodeficiency Diseases
Peking University People's Hospital 15
Early research (Phase 1)Ended earlyNCT00006153
What this trial is testing

Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Not applicableStudy completedNCT03369301
What this trial is testing

The Effect of Subcutaneous Immunoglobulin Gammanorm on the Distribution of IgG Subclasses and on Immunity of Patients With Secondary Immunodeficiency

Who this might be right for
Secondary Immune Deficiency
Octapharma 102
Early research (Phase 1)UnknownNCT00062530
What this trial is testing

Safety of an Oral HIV Vaccine in HIV Uninfected Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 38
Testing effectiveness (Phase 2)Study completedNCT03721510
What this trial is testing

A Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected Adults

Who this might be right for
HIV/AIDS
International AIDS Vaccine Initiative 19
Testing effectiveness (Phase 2)Study completedNCT02716675
What this trial is testing

Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 2,699
Early research (Phase 1)Study completedNCT00000904
What this trial is testing

Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Large-scale testing (Phase 3)Study completedNCT03961009
What this trial is testing

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients

Who this might be right for
Primary Immunodeficiency Disease
Kedrion S.p.A. 47
Large-scale testing (Phase 3)Study completedNCT02911857
What this trial is testing

An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes

Who this might be right for
Periodic Fevers Syndrome
Novartis Pharmaceuticals 4
Early research (Phase 1)Study completedNCT00260702
What this trial is testing

Omalizumab to Treat Hyper-IgE (Job's) Syndrome

Who this might be right for
Hyper-IgE SyndromeJob's Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 1
Large-scale testing (Phase 3)Study completedNCT00814320
What this trial is testing

Gammagard Liquid and rHuPH20 in PID

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 89
Testing effectiveness (Phase 2)Looking for participantsNCT06976476
What this trial is testing

Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Who this might be right for
Multiple MyelomaHypogammaglobulinemiaHypogammaglobulinemia, Acquired
Memorial Sloan Kettering Cancer Center 100
Early research (Phase 1)Study completedNCT00002231
What this trial is testing

Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers

Who this might be right for
HIV InfectionsHIV Seronegativity
Wyeth-Lederle Vaccines
Not applicableLooking for participantsNCT06497829
What this trial is testing

Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency

Who this might be right for
Mevalonate Kinase Deficiency
University Hospital, Motol 6
Large-scale testing (Phase 3)Study completedNCT03730129
What this trial is testing

Humoral Immunodeficiency in CLL and Therapy With Subcutaneous Ig

Who this might be right for
Secondary Immune Deficiency Disorder
Rochester General Hospital 20
Not applicableStudy completedNCT04711265
What this trial is testing

Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys

Who this might be right for
HPV VaccineHPV InfectionHIV-1-infection
Kenya Medical Research Institute 176
Load More Results